<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">2580</id>
  <title>T3D2539</title>
  <common-name>Calciseptine </common-name>
  <description>Calciseptine is a peptide toxin produced by the Black mamba (Dendroaspis polylepis polylepis). It is a smooth muscle relaxant and an inhibitor of cardiac contractions. (T170)</description>
  <cas>134710-25-1</cas>
  <pubchem-id></pubchem-id>
  <chemical-formula nil="true"/>
  <weight>7044.154999999995</weight>
  <appearance>Clear solution.</appearance>
  <melting-point></melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility>&gt;10 mg/mL</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Injection (sting/bite) (L1814)</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Calciseptine is a specific blocker of the L-type calcium channel, and as a result also a smooth muscle relaxant and an inhibitor of cardiac contractions. (T170)</mechanism-of-toxicity>
  <metabolism>Free toxin may be removed by opsonization via the reticuloendothelial system (primarily the liver and kidneys) or it may be degraded through cellular internalization via the lysosomes. Lysosomes are membrane-enclosed organelles that contain an array of digestive enzymes, including several proteases.</metabolism>
  <toxicity>LD50: 0.32 mg/kg (Subcutaneous, Mouse) (L1830)
LD50: 0.25 mg/kg (Intravenous, Mouse) (L1830)
LD50: 0.941 (Intraperitoneal, Mouse) (L1830)</toxicity>
  <lethaldose></lethaldose>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>Calciseptine is a peptide toxin produced by the Black mamba (Dendroaspis polylepis polylepis). (T170)</use-source>
  <min-risk-level></min-risk-level>
  <health-effects>Calciseptine is neurotoxic. (L1716)</health-effects>
  <symptoms>Bites from snakes in the Elapidae family produce pain at the site of the bite, followed by drowsiness, weakness, excessive salivation, decreased blood pressure, difficulty breathing, and paralysis of the facial muscles, lips, tongue, and larynx. In addition, ptosis, blurring of vision, convulsions, and headache may occur. (T156)</symptoms>
  <treatment>An antivenom exists for Black mamba venom. (L1044)</treatment>
  <created-at type="dateTime">2009-07-03T22:19:16Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:25:40Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia></wikipedia>
  <uniprot-id>P22947</uniprot-id>
  <kegg-compound-id></kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id></chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id></ctd-id>
  <stitch-id></stitch-id>
  <drugbank-id></drugbank-id>
  <pdb-id></pdb-id>
  <actor-id></actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles nil="true"/>
  <moldb-formula nil="true"/>
  <moldb-inchi nil="true"/>
  <moldb-inchikey nil="true"/>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal" nil="true"/>
  <origin>Exogenous</origin>
  <state>Liquid</state>
  <logp></logp>
  <hmdb-id></hmdb-id>
  <chembl-id></chembl-id>
  <chemspider-id></chemspider-id>
  <structure-image-file-name>1tfs_asym_r_500.jpg</structure-image-file-name>
  <structure-image-content-type>image/jpeg</structure-image-content-type>
  <structure-image-file-size type="integer">42729</structure-image-file-size>
  <structure-image-updated-at type="dateTime">2014-10-14T18:13:10Z</structure-image-updated-at>
  <biodb-id>BSEQ0008458</biodb-id>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
